ArticleOncology letters2025

Recombinant human‑endostatin combined with sintilimab and chemotherapy in first‑line treatment of locally advanced or metastatic esophageal squamous cell carcinoma.

Shiyun Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.